Nuvama cuts target price on Alkem Lab: Find out why?

Nuvama Institutional Equities cut the target price on Alkem Laboratories by 3.5% to Rs 5,840 from Rs 6,053 as the brokerage house sees a slowdown in acute business. It retained its ‘Hold’ call on the stock. It also slashed the earnings per share estimates by 3% for FY26 and 2% for FY27. It further cut the return on equity estimate to 17% in FY27. 

The brokerage firm said that the company’s domestic business declined sequentially, which reflects a slowdown in the acute business. Adding, the impact of no price hike in the NLEM portfolio, which makes up 30% of domestic revenue. 

Alkem Laboratories’ domestic business in the third quarter of the current fiscal year dropped 4% sequentially to Rs 2,400 crore. However, it grew 6% year-on-year. The domestic business missed Nuvama’s estimates. 

Also Read HDFC AMC shares jump 5%. Here are 4 reasons why brokerages are bullish Nomura maintains Buy on ITC. Here are 3 reasons why… ‘US to deport 7.25 lakh Indians’, Rajiv Shukla shares key data, ‘they were earning good, suddenly turned…’ Why is the stock market falling today? Here are 3 reasons…

Not just domestic business, but international business also faced some heat. The US exports contracted 7% YoY while the international exports contracted 14% YoY. However, the brokerage firm thinks that it may return to normal levels with growth in the domestic acute and US generics. 

“We note Alkem’s gross margin in 9MFY25 is attractive; however, this may not sustain in FY26E with growth in domestic acute and US generics business. We think cost optimisation is necessary to expand EBITDA margin,” said Nuvama in a research note. 

Further, it said that acquisitions have a small quantum as the company recently acquired Bombay Ortho and Adroit Biomed, which made a combined revenue of Rs 60 crore for FY24, 0.5% of consolidated revenue. “We note, that under new management, Alkem is making some hard decisions (divestment/M&A), even though the quantum is very small for now,” Nuvama said. 

Alkem Laboratories in Q3

The company’s consolidated net profit rose 6% YoY to Rs 641 crore from Rs 604 crore in Q3 FY24. Sequentially, profit fell almost 9% from 702 crore in the previous quarter of the same financial year. Its total income for the quarter stood at Rs 3,467 crore,

 » Read More

Related Articles

BluSmart denies reports of acquisition discussions with Uber

EV cab aggregator BluSmart has denied reports of being in discussions or negotiations with Uber regarding a possible acquisition. A spokesperson from BluSmart told CNBC TV18 that reports suggesting such a development are entirely speculative and unfounded.  The company spokesperson further maintained that BluSmart remains focused on scaling its operations, expanding its footprint, and driving

Welspun Corp bags new orders worth Rs 2,400 crore for supply of coated pipes in the US

Welspun Corp Ltd on Monday announced that it has received a new order worth Rs 2,400 crore (approx) in the US. The order, it added, is for supply of coated pipes for Natural Gas Pipeline Projects in the USA.  In a regulatory filing, the company said that the orders will be executed largely during FY26

Can the Nifty scale past 23,000 this week? A look at key levels to watch

All eyes are on the market levels this week after the Nifty failed to close above 22,500 last week. Positive global cues are expected to boost sentiment. Market participants have noted that the Nifty 50 needs to jump above the 22,500 mark decisively for an uptrend as this has become a key resistance level while

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

BluSmart denies reports of acquisition discussions with Uber

EV cab aggregator BluSmart has denied reports of being in discussions or negotiations with Uber regarding a possible acquisition. A spokesperson from BluSmart told CNBC TV18 that reports suggesting such a development are entirely speculative and unfounded.  The company spokesperson further maintained that BluSmart remains focused on scaling its operations, expanding its footprint, and driving

Welspun Corp bags new orders worth Rs 2,400 crore for supply of coated pipes in the US

Welspun Corp Ltd on Monday announced that it has received a new order worth Rs 2,400 crore (approx) in the US. The order, it added, is for supply of coated pipes for Natural Gas Pipeline Projects in the USA.  In a regulatory filing, the company said that the orders will be executed largely during FY26

Can the Nifty scale past 23,000 this week? A look at key levels to watch

All eyes are on the market levels this week after the Nifty failed to close above 22,500 last week. Positive global cues are expected to boost sentiment. Market participants have noted that the Nifty 50 needs to jump above the 22,500 mark decisively for an uptrend as this has become a key resistance level while

Upcoming Dividend, Bonus, Stock Split: From PFC to IRFC, A look at key corporate action this week

For stock market investors, few things are as exciting as corporate rewards such as dividends landing in their accounts, extra shares through bonuses, or stock splits making pricey stocks more affordable. And this week, there is a lot happening on that front. Some of the most watched stocks include Indian Railway Finance Corporation (IRFC), Power

Upcoming IPOs: 1 mainboard, 3 SME issues open for subscription this week, 2 new listings to hit the market

The IPO market is back in action. After a relatively quiet spell, the primary market is heating up again with four new public issues set to open for subscription this week. Investors can look forward to one mainboard IPO and three SME IPOs hitting the Street, while two recently concluded issues will make their market